Clinical Study of Jianpi Bufei Huatan Recipe for Treatment of Pediatric Bronchial Asthma at Remission Stage
10.13359/j.cnki.gzxbtcm.2016.01.003
- VernacularTitle:健脾补肺化痰方对小儿支气管哮喘缓解期肺功能的影响
- Author:
Minyong GU
;
Lili SHANG
;
Yanli SUN
- Publication Type:Journal Article
- Keywords:
Jianpi Bufei Huatan Recipe/therapeutic use;
pediatric bronchial asthma/TCD therapy;
remission stage;
lung-spleen qi deficiency;
pulmonary function
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2016;(1):8-11
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the influence of Jianpi Bufei Huatan Recipe (JBHR), a Chinese herbal compound with the actions of strengthening spleen, tonifying lung and resolving phlegm, on the pulmonary function of childhood bronchial asthma at remission stage, and to explore the possible therapeutic mechanism. Methods Sixty bronchial asthma children at remission stage were divided into treatment group and control group, 30 cases in each group. Both groups were treated with inhalation of fluticasone propionate, and additionally, the treatment group was given oral use of JBHR(mainly composed of Radix Astragali, Radix Pseudostellariae, fried Rhizoma Atrctylodis Macrocephalae, Radix Saposhnikoviae, Poria, Pericarpium Citri Reticulatae, Rhizoma Pinelliae, prepared Radix Glycyrrhizae, calcined Os Draconis, calcined Concha Ostreae, and Semen Lepidii seu Descurainiae). The therapeutic effect of the two groups was evaluated after treatment, and the changes of peak expiratory flow(PEF), peak expiratory flow variation(PEFv) were also observed after treatment for 1, 2, 3, 6, 9, a nd 12 month(s). Results (1)The total effective rate of the treatment group was 93.33%, and that of the control group was 83.33%, the difference being significant(P<0.05). (2) During the treatment, PEF was higher and PEFv was lower in the treatment group than those in the control group(P<0.05). Conclusion JBHR could relieve the clinical symptoms, improve the pulmonary function and decrease the hyperactivity of airway of pediatric bronchial asthma at remission stage with lung-spleen qi deficiency.